Similar articles

• Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.

  Takes RP. Takes RP. Oral Oncol. 2004 Aug;40(7):656-67. doi: 10.1016/j.oraloncology.2003.11.001. Oral Oncol. 2004. PMID: 15172634 Review.
• Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.

  Colnot DR, Nieuwenhuis EJ, Kuik DJ, Leemans CR, Dijkstra J, Snow GB, van Dongen GA, Brakenhoff RH. Colnot DR, et al. Clin Cancer Res. 2004 Dec 1;10(23):7827-33. doi: 10.1158/1078-0432.CCR-04-1090. Clin Cancer Res. 2004. PMID: 15585614
• The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.

  Palme CE, MacKay SG, Kalnins I, Morgan GJ, Veness MJ. Palme CE, et al. Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):103-6. doi: 10.1097/MOO.0b013e3280586723. Curr Opin Otolaryngol Head Neck Surg. 2007. PMID: 17413411 Review.
• Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.

  Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST. Ch'ng S, et al. J Plast Reconstr Aesthet Surg. 2006;59(12):1288-93. doi: 10.1016/j.bjps.2006.03.043. Epub 2006 Jun 5. J Plast Reconstr Aesthet Surg. 2006. PMID: 17113505
• Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.

  Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA. Rodrigues RS, et al. J Nucl Med. 2009 Aug;50(8):1205-13. doi: 10.2967/jnumed.109.062075. Epub 2009 Jul 17. J Nucl Med. 2009. PMID: 19617339